Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England

Christopher J. McDermott, R. K. Dayaratne, J. Tomkins, M. E. Lusher, J. C. Lindsey, M. A. Johnson, G. Casari, D. M. Turnbull, K. Bushby, P. J. Shaw

Research output: Contribution to journalArticle

Abstract

Objective: To identify the frequency and characterize the phenotype of paraplegin mutations in the hereditary spastic paraparesis (HSP) population in the northeast of England. Background: HSP is a disorder that shows both clinical and genetic heterogeneity. To date, 13 loci have been associated with an HSP phenotype, with the causative gene having been identified in four of these. Two autosomal genes have been identified, paraplegin and spastin, and two X-linked genes have been identified, L1CAM (cell adhesion molecule) and proteolipid protein. Methods: Thirty HSP pedigrees from the northeast of England were analyzed for mutation in each of the 17 exons of the paraplegin gene. Results: A single family with a paraplegin mutation was identified in which the paraplegin mutation co-segregates with an HSP phenotype in an apparent dominant manner. The authors also describe frequent polymorphism in the paraplegin gene in both the HSP and control populations. Conclusion: Mutations in the paraplegin gene are not a common cause of HSP in the northeast of England. The phenotype of the paraplegin-related HSP family described had several striking features including amyotrophy, raised creatine kinase, sensorimotor peripheral neuropathy, and oxidative phosphorylation defect on muscle biopsy.

Original languageEnglish
Pages (from-to)467-471
Number of pages5
JournalNeurology
Volume56
Issue number4
Publication statusPublished - Feb 27 2001

Fingerprint

Spastic Paraparesis
Pedigree
England
Genes
Mutation
Phenotype
Neural Cell Adhesion Molecule L1
Proteolipids
X-Linked Genes
Genetic Heterogeneity
Oxidative Phosphorylation
Cell Adhesion Molecules
Peripheral Nervous System Diseases
Creatine Kinase
Population
Exons
Biopsy
Muscles

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

McDermott, C. J., Dayaratne, R. K., Tomkins, J., Lusher, M. E., Lindsey, J. C., Johnson, M. A., ... Shaw, P. J. (2001). Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology, 56(4), 467-471.

Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. / McDermott, Christopher J.; Dayaratne, R. K.; Tomkins, J.; Lusher, M. E.; Lindsey, J. C.; Johnson, M. A.; Casari, G.; Turnbull, D. M.; Bushby, K.; Shaw, P. J.

In: Neurology, Vol. 56, No. 4, 27.02.2001, p. 467-471.

Research output: Contribution to journalArticle

McDermott, CJ, Dayaratne, RK, Tomkins, J, Lusher, ME, Lindsey, JC, Johnson, MA, Casari, G, Turnbull, DM, Bushby, K & Shaw, PJ 2001, 'Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England', Neurology, vol. 56, no. 4, pp. 467-471.
McDermott CJ, Dayaratne RK, Tomkins J, Lusher ME, Lindsey JC, Johnson MA et al. Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. Neurology. 2001 Feb 27;56(4):467-471.
McDermott, Christopher J. ; Dayaratne, R. K. ; Tomkins, J. ; Lusher, M. E. ; Lindsey, J. C. ; Johnson, M. A. ; Casari, G. ; Turnbull, D. M. ; Bushby, K. ; Shaw, P. J. / Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England. In: Neurology. 2001 ; Vol. 56, No. 4. pp. 467-471.
@article{a4a94efb3ce743a9a40406f88085d31d,
title = "Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England",
abstract = "Objective: To identify the frequency and characterize the phenotype of paraplegin mutations in the hereditary spastic paraparesis (HSP) population in the northeast of England. Background: HSP is a disorder that shows both clinical and genetic heterogeneity. To date, 13 loci have been associated with an HSP phenotype, with the causative gene having been identified in four of these. Two autosomal genes have been identified, paraplegin and spastin, and two X-linked genes have been identified, L1CAM (cell adhesion molecule) and proteolipid protein. Methods: Thirty HSP pedigrees from the northeast of England were analyzed for mutation in each of the 17 exons of the paraplegin gene. Results: A single family with a paraplegin mutation was identified in which the paraplegin mutation co-segregates with an HSP phenotype in an apparent dominant manner. The authors also describe frequent polymorphism in the paraplegin gene in both the HSP and control populations. Conclusion: Mutations in the paraplegin gene are not a common cause of HSP in the northeast of England. The phenotype of the paraplegin-related HSP family described had several striking features including amyotrophy, raised creatine kinase, sensorimotor peripheral neuropathy, and oxidative phosphorylation defect on muscle biopsy.",
author = "McDermott, {Christopher J.} and Dayaratne, {R. K.} and J. Tomkins and Lusher, {M. E.} and Lindsey, {J. C.} and Johnson, {M. A.} and G. Casari and Turnbull, {D. M.} and K. Bushby and Shaw, {P. J.}",
year = "2001",
month = "2",
day = "27",
language = "English",
volume = "56",
pages = "467--471",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Paraplegin gene analysis in hereditary spastic paraparesis (HSP) pedigrees in northeast England

AU - McDermott, Christopher J.

AU - Dayaratne, R. K.

AU - Tomkins, J.

AU - Lusher, M. E.

AU - Lindsey, J. C.

AU - Johnson, M. A.

AU - Casari, G.

AU - Turnbull, D. M.

AU - Bushby, K.

AU - Shaw, P. J.

PY - 2001/2/27

Y1 - 2001/2/27

N2 - Objective: To identify the frequency and characterize the phenotype of paraplegin mutations in the hereditary spastic paraparesis (HSP) population in the northeast of England. Background: HSP is a disorder that shows both clinical and genetic heterogeneity. To date, 13 loci have been associated with an HSP phenotype, with the causative gene having been identified in four of these. Two autosomal genes have been identified, paraplegin and spastin, and two X-linked genes have been identified, L1CAM (cell adhesion molecule) and proteolipid protein. Methods: Thirty HSP pedigrees from the northeast of England were analyzed for mutation in each of the 17 exons of the paraplegin gene. Results: A single family with a paraplegin mutation was identified in which the paraplegin mutation co-segregates with an HSP phenotype in an apparent dominant manner. The authors also describe frequent polymorphism in the paraplegin gene in both the HSP and control populations. Conclusion: Mutations in the paraplegin gene are not a common cause of HSP in the northeast of England. The phenotype of the paraplegin-related HSP family described had several striking features including amyotrophy, raised creatine kinase, sensorimotor peripheral neuropathy, and oxidative phosphorylation defect on muscle biopsy.

AB - Objective: To identify the frequency and characterize the phenotype of paraplegin mutations in the hereditary spastic paraparesis (HSP) population in the northeast of England. Background: HSP is a disorder that shows both clinical and genetic heterogeneity. To date, 13 loci have been associated with an HSP phenotype, with the causative gene having been identified in four of these. Two autosomal genes have been identified, paraplegin and spastin, and two X-linked genes have been identified, L1CAM (cell adhesion molecule) and proteolipid protein. Methods: Thirty HSP pedigrees from the northeast of England were analyzed for mutation in each of the 17 exons of the paraplegin gene. Results: A single family with a paraplegin mutation was identified in which the paraplegin mutation co-segregates with an HSP phenotype in an apparent dominant manner. The authors also describe frequent polymorphism in the paraplegin gene in both the HSP and control populations. Conclusion: Mutations in the paraplegin gene are not a common cause of HSP in the northeast of England. The phenotype of the paraplegin-related HSP family described had several striking features including amyotrophy, raised creatine kinase, sensorimotor peripheral neuropathy, and oxidative phosphorylation defect on muscle biopsy.

UR - http://www.scopus.com/inward/record.url?scp=0035957066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035957066&partnerID=8YFLogxK

M3 - Article

C2 - 11222789

AN - SCOPUS:0035957066

VL - 56

SP - 467

EP - 471

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 4

ER -